cvs xkhtm form cvs united states securities and exchange commission washington dc form annual report pursuant section dof securities exchange act for fiscal year ended december or transition report pursuant section dof securities exchange act for transition period commission file number cvs health corporation exact name registrant specified charter delaware state jurisdiction incorporation organization irs employer identification no one cvs drive woonsocket rhode island address principal executive offices zip code registrants telephone number including area code securities registered pursuant sectionbof exchange act common stock par value per share new york stock exchange title class name exchange registered securities registered pursuant sectiongof exchange act none indicate check mark registrant well known seasoned issuer defined rule securities actyes no indicate check mark registrant required file reports pursuant section sectiondof actyes no indicate check mark whether registrant filed reports required filed section dof securities exchange act preceding months shorter period registrant required file reports subject filing requirements past daysyes no indicate check mark whether registrant submitted electronically posted corporate website every interactive data file required submitted posted pursuant rule regulation preceding months shorter period registrant required submit post filesyes no indicate check mark disclosure delinquent filers pursuant item regulation contained herein contained best registrants knowledge definitive proxy information statements incorporated reference partiii form amendment form indicate check mark whether registrant large accelerated filer accelerated filer non accelerated filer smaller reporting company see definition large accelerated filer accelerated filer smaller reporting company ruleb exchange act largeacceleratedfiler accelerated filer non accelerated filer do check smaller reporting company smaller reporting company indicate check mark whether registrant shell company defined ruleb actyes no the aggregate market value registrants common stock held non affiliates approximately june based closing price common stock new york stock exchange for purposes calculation executive officers directors deemed affiliates registrant as february registrant shares common stock issued outstanding documents incorporated by reference filings made companies securities exchange commission sometimes incorporate information reference this means company referring information previously filed filed sec information considered part filing reading the following materials incorporated reference form portions annual report stockholders fiscal year ended december incorporated reference response items partii information contained proxy statement annual meeting stockholders incorporated reference response items partiii table of contents page parti item business itema risk factors itemb unresolved staff comments item properties item legal proceedings item mine safety disclosures executive officers registrant partii item market registrants common equity related stockholder matters issuer purchases equity securities item selected financial data item managements discussion analysis financial condition results operations itema quantitative qualitative disclosures about market risk item financial statements supplementary data item changes disagreements accountants accounting financial disclosure itema controls procedures itemb other information partiii item directors executive officers corporate governance item executive compensation item security ownership certain beneficial owners management related stockholder matters item certain relationships related transactions director independence item principal accountant fees services partiv item exhibits financial statement schedules signatures parti item business overview cvs health corporation together subsidiaries collectively cvs health company us pharmacy innovation company helping people path better health at forefront changing health care landscape company unmatched suite capabilities expertise needed drive innovations help shape future health we currently integrated pharmacy health care company ability impact consumers payors providers innovative channel agnostic solutions we deep understanding diverse needs unique integrated model bringing innovative solutions help increase access quality care deliver better health outcomes lower overall health care costs through retail pharmacies walk medical clinics leading pharmacy benefits manager million plan members expanding specialty pharmacy services enable people businesses communities manage health effective ways we delivering break products services advising patients medications cvspharmacy locations introducing unique programs help control costs clients cvscaremark innovating care delivered patients complex conditions cvsspecialty expanding access high quality low cost care cvsminuteclinic we currently three reportable segments pharmacy services retail pharmacy corporate pharmacy services segment the pharmacy services segment provides full range pharmacy benefit management pbm services described fully clients consisting primarily employers insurance companies unions government employee groups health plans managed medicaid plans plans offered public private exchanges sponsors health benefit plans individuals throughout united states in addition silverscript insurance company silverscript subsidiary national provider drug benefits eligible beneficiaries federal governments medicare partd program the pharmacy services segment operates cvscaremark tm pharmacy services caremark careplus cvspharmacy rxamerica accordant silverscript coram cvsspecialty tm novologix navarro health services names as december pharmacy services segment operated retail specialty pharmacy stores specialty mail order pharmacies four mail order dispensing pharmacies branches including approximately ambulatory infusion suites six centers excellence infusion enteral services located states puerto rico district columbia during year ended december pbm filled managed approximately million prescriptions pharmacy services business strategy our business strategy centers providing innovative pharmaceutical solutions quality client service order help improve clinical outcomes clients health benefit plan members assisting clients plan members better managingoverall health care costsour goal produce superior results clients plan membersby leveragingour expertise core pbm services includingplan design offerings administration formulary management medicare partd services mail order specialty pharmacy infusion services retail pharmacy network management services prescription management systems clinical services disease management services medical spend management in addition fully integrated pharmacy services company able offer clients plan members variety programs plan designs benefit integrated systems ability pharmacists nurses nurse practitioners physician assistants interact personally many plan members shop stores every daythrough multiple member touch points retail stores mail order infusion specialty pharmacies retail medical clinics call centers proprietary websites mobile devices seek engage plan members behaviors help lower cost improve health care outcomesexamples programs services include maintenance choice program eligible client plan members elect fill maintenance prescriptions retail pharmacy stores price mail order pharmacy advisor program facilitates face face telephone counseling pharmacists help participating plan members certain chronic diseases diabetes cardiovascular conditions identify gaps care adhere prescribed medications manage health conditions compliance persistency programs designed help ensure patients take medications proper manner enhanced disease management programs targeted managing chronic disease states extracare health card program offers discounts eligible plan members certain counter health care products sold cvspharmacy storesin addition minuteclinic important differentiated part enterprise offers certain capabilities available pbm members ways working clients include partnerships health plan clients sponsoring patient centered medical homes biometric screening opportunities closing gaps care plan sponsored co pay reductions encourage use minuteclinic onsite clinics client corporate headquarters pbm services our pbm services described fully plan design offerings administration our clients sponsor pharmacy benefit plans facilitate ability eligible members plans receive prescribed medications we assist clients designing pharmacy benefit plans help minimize costs client prioritizing welfare safety clients members helping improve health outcomes we also administer benefit plans selected clients assist monitoring effectiveness plans frequent informal communications well formal annual client review we make recommendations clients helping design benefit plans promoting use lower cost clinically appropriate drug we help clients control costs offering plan designs encourage use generic equivalents brand name drugs equivalents available our clients also option plan design lower pharmacy benefit plan costs setting different member payment levels different products drug lists formularies formulary management we utilize independent panel doctors pharmacists medical experts referred pharmacy therapeutics committee select drugs meet highest standards safety efficacy inclusion formularies our formularies provide recommended products numerous drug classes ensure member access clinically appropriate alternatives clients pharmacy benefit plan to help improve clinical outcomes members clients conduct ongoing independent reviews drugs including limited appearing formularies generic equivalent products well clinical programs many clients choose adopt template formulary offerings part plan design medicare partd services we participate administration drug benefit added medicare program partd medicare prescription drugimprovement modernization act mma provision pbm services health plan clients clients qualified medicare partd prescription drug plans pdp offering medicare partd pharmacy benefits silverscript pdp approved centers medicare medicaid services cms we also assist employer union health plan clients qualify retiree drug subsidy made available mma collecting submitting eligibility andor drug cost data cms order obtain subsidy mail order pharmacy as december operated four mail order dispensing pharmacies united states plan members prescribers submit prescriptions refill requests primarily maintenance medications pharmacies via mail telephone fax prescribing internet we also operate network smaller mail order specialty pharmacies described our staff pharmacists review mail order prescriptions refill requests assistance prescription management systems this review may involve communications prescriber prescribers approval required result generic substitution therapeutic interchange actions designed help reduce cost andor improve quality treatment these pharmacies awarded mail order pharmacy accreditation utilization review accreditation commission urac washington dc based health care accrediting organization establishes quality standards health care industry specialty pharmacy our specialty pharmacies support individuals require complex expensive drug therapies as december specialty pharmacy operations included specialty mail order pharmacies located throughout united states used delivery advanced medications individuals chronic genetic diseases disorders substantially pharmacies accredited joint commission independent profit organization accredits certifies health care organizations programs united states these pharmacies also awarded specialty pharmacy accreditation urac as december company operated network retail specialty pharmacy stores operate careplus cvspharmacy navarro health services names these stores average square feet size sell prescription drugs limited assortment front store items alternative medications homeopathic remedies vitamins in january enhanced offerings specialty infusion services began offering enteral nutrition services coram llc subsidiaries collectively coram acquired january coram one nations largest providers comprehensive infusion services caring approximately patients annually in may implemented specialty connect tm integrates specialty pharmacy mail retail capabilities providing members disease state specific counseling experienced specialty pharmacists choice bring specialty prescriptions cvspharmacy location whether submitted mail order pharmacy cvspharmacy prescriptions filled companys specialty mail order pharmacies revenue specialty prescription services program recorded within pharmacy services segment members choose pick medication local cvspharmacy sent home mail retail pharmacy network management we maintain national network retail pharmacies consisting approximately chain pharmacies includes cvspharmacy stores independent pharmacies united states puerto rico district columbia guam virgin islands when customer fills prescription retail pharmacy pharmacy sends prescription data electronically us point sale this data interfaces proprietary prescription management systems verify relevant plan member data eligibility also performing drug utilization review help evaluate clinical appropriateness safety confirming pharmacy receive payment prescription prescription management systems we dispense prescription drugs directly one mail order specialty pharmacies network retail pharmacies described all prescriptions processed systems whether filled one mail order dispensing pharmacies pharmacy retail network analyzed processed documented proprietary prescription management systems these systems assist staff network pharmacists processing prescriptions automating review various items including limited plan eligibility early refills duplicate dispensing appropriateness dosage drug interactions allergies utilization potential fraud clinical services we offer multiple clinical programs services help clients manage overall pharmacy health care costs clinically appropriate manner our programs primarily designed promote safety help target inappropriate utilization non adherence medication may result adverse medical events negatively impact member health client pharmacy medical spend in regard offer various utilization management medication management quality assurance adherence counseling programs complement clients plan design clinical strategies disease management programs our clinical services utilize advanced protocols offer clients convenience working health care providers third parties our accordant programs include integrated rare disease management programs cover diseases rheumatoid arthritis parkinsons disease seizure disorders multiple sclerosis the majority integrated programs accredited national committee quality assurance ncqa private profit organization evaluates accredits certifies wide range health care organizations they also awarded case management accreditation urac medical pharmacy management we offer technology platform helps identify capture cost savings opportunities specialty drugs billed medical benefit helps ensure appropriate clinical use drugs pharmacy services information systems we currently operate small number claim adjudication platforms support pharmacy services segment however majority clients migrated one destination platform these information systems incorporate architecture centralizes data generated filling mail order prescriptions adjudicating retail pharmacy claims fulfilling services provide pbm clients pharmacy services clients our clients primarily employers insurance companies unions government employee groups health plans managed medicaid plans plans offered public private exchanges sponsors health benefit plans individuals located throughout united states we provide pharmaceuticals eligible members benefit plans maintained clients utilize information systems among things help perform safety checks drug interaction screening identify opportunities generic substitution we generate substantially pharmacy services segment net revenue dispensing prescription drugs eligible members benefit plans maintained clients no single pbm client accounts annual consolidated revenues pharmacy services seasonality the majority pharmacy services segment revenues seasonal nature however quarterly earnings operating cash flows impacted medicare part benefit design changes composition membership the medicare part standard benefit design results coverage varies member cumulative annual pocket costs the benefit design generally results plan sponsors sharing greater portion responsibility total prescription drug costs early part year as result pdp plan pay percentage benefit ratio generally decreases operating profit generally increases year progresses pharmacy services competition we believe primary competitive factors industry include ithe ability negotiate favorable discounts drug manufacturers iithe ability negotiate favorable discounts access retail pharmacy networks iiiresponsiveness clients needs ivthe ability identify apply effective cost management programs utilizing clinical strategies vthe ability develop utilize preferred formularies vithe ability market pbm products services viithe commitment provide flexible clinically oriented services clients viiithe quality scope costs products services offered clients members ix operational excellence delivering services the pharmacy services segment significant number competitors offering pbm services eg express scripts optumrx catamaran prime therapeutics medimpact humana including large national pbm companies pbms owned large national health plans smaller standalone pbms retail pharmacy segment as december retail pharmacy segment included retail drugstores operated pharmacy online retail pharmacy websites cvscom navarrocom tm onofrecombr tm onsite pharmacy stores retail health care clinics the retail drugstores located states district columbia puerto rico brazil operating primarily cvspharmacy cvs longs drugs navarro discount pharmacy drogaria onofre tm names we currently operate top united states drugstore markets hold number one number two market share markets the retail pharmacy segment sells prescription drugs wide assortment counter personal care products beauty cosmetic products general merchandise refer front store products existing retail stores range size approximately square feet although new stores range size approximately square feet typically include drive thru pharmacy during filled million retail prescriptions counting day prescriptions one prescription approximately united states retail pharmacy market in retail drugstores became first pharmacies nation receive community pharmacy accreditation urac retail pharmacy business strategy our integrated pharmacy services model enhanced ability retail pharmacy stores expand customer access care helping lower overall health care costs improve health outcomes in regard role retail pharmacist shifting primarily dispensing prescriptions also providing services including flu vaccinations well face face patient counseling respect adherence drug therapies closing gaps care recommending cost effective drug therapies in addition personalization central retail strategy our customer driven personalization extracare extracare beauty club myweeklyad tm designed help us connect directly individual consumers deliver personalized experience we also provide broad assortment quality merchandise competitive prices using retail format emphasizes service innovation convenience one keys strategy technology allows us focus constantly improving service exploring ways provide personalized product offerings services we believe continuing first market new unique products services using innovative marketing adjusting mix merchandise match customers needs preferences important ability continue improve customer satisfaction retail pharmacy products services typical retail store sells prescription drugs wide assortment high quality nationally advertised brand name proprietary brand merchandise front store categories include counter drugs beauty products cosmetics personal care products convenience foods photo finishing services seasonal merchandise greeting cards we purchase merchandise numerous manufacturers distributors we believe competitive sources readily available substantially products carry loss one supplier would likely material effect business retail pharmacy segment net revenues major product group follows percentageofnetrevenues prescription drugs over counter personal care beautycosmetics general merchandise percentages estimates based store point sale data pharmacy pharmacy revenues represented two thirds retail pharmacy revenues we believe pharmacy operations continue represent critical part business due favorable industry trends eg aging american population consuming greater number prescription drugs pharmaceuticals used often first line defense managing illness impact expanded health insurance coverage patient protection affordable care act health care education reconciliation act collectively aca introduction new pharmaceutical products medicare partd we believe pharmacy business benefits investment people technology well innovative partnerships health plans pbms providers given nature prescriptions people want prescriptions filled accurately professional pharmacists using latest tools technology ready promised consumers need medication management programs better information help get health care dollars to assist customers needs introduced integrated pharmacy health care services provide earlier easier effective approach engaging behaviors help lower costs improve health save lives examples include patient care initiative enhanced medication adherence program maintenance choice program eligible client plan members elect fill maintenance prescriptions retail pharmacy stores price mail order pharmacy advisor program facilitates pharmacist counseling face face telephone help participating plan members certain chronic diseases diabetes cardiovascular conditions identify gaps care adhere prescribed medications manage health conditions well specialty connect tm integrated specialty pharmacy offering began integrates specialty mail retail capabilities providing members disease state specific counseling experienced specialty pharmacists choice bring specialty prescriptions cvspharmacy location submit specialty mail order pharmacies maintenance choice pharmacy advisor specialty connect programs demonstrate ability enhance customer experience integrated enterprise products services further evidencing belief importance pharmacy service continuing investment technology drug utilization review system helps check harmful interactions prescription drugs patient identified counter products vitamins herbal remedies proprietary pharmacy system integrates product delivery clinical workflows well advanced patient safety functionality drug utilization review rx connect prescription refill program readyfill online retail businesses cvscom navarrocom onofrecombr front store front store revenues benefited strategy first market new unique products services using innovative personalized marketing adjusting mix merchandise match customers needs preferences key component front store strategy extracare card program helping us continue build loyal customer base the extracare program one largest successful retail loyalty programs united states the extracare program allows us balance marketing efforts reward best customers providing automatic sale prices customized coupons extrabucks rewards benefits similar extracare beauty club another program rewards loyal customers sales prices customized coupons we continue launch new exclusive brands like salma hayek nuance tm makeup academy tm nyx create unmatched offerings beauty another component front store strategy unique product offerings include full range high quality cvspharmacy proprietary brand products available cvspharmacy stores we currently carry cvspharmacy proprietary brand products accounted approximately front store revenues these products include expanded offerings healthy foods vitamins furthermore tailoring certain groups stores suburban area stores better meet needs customers minuteclinic as december operated minuteclinic locations states district columbia located cvspharmacy storeswe opened new clinics minuteclinics staffed nurse practitioners physician assistants utilize nationally established guidelines diagnose treat minor health conditions perform health screenings monitor chronic conditions provide wellness services deliver vaccinations insurers value minuteclinic provides convenient high quality cost effective care many cases offering attractive alternative expensive sites careas result visits paid employers health insurers third parties accounted approximately minuteclinics total revenues minuteclinic collaborating pharmacy services segment help meet needs cvscaremarks client plan members offering programs improve member health lower costs minuteclinic affiliated major health systems continues build platform supports primary care onsite pharmacies we also operate limited number small pharmacies located client sites careplus careplus cvspharmacy cvspharmacy wellness works pharmacy name provide certain health plan members customers convenient alternative filling prescriptions retail pharmacy store development the addition new stores played continue play key role continued growth success our store development program focuses three areas entering new markets adding stores within existing markets relocating stores convenient sites during opened new retail pharmacy stores acquired stores relocated stores closed stores during last five years opened new relocated stores acquired stores during expect square footage growth approximately we believe continuing grow store base locating stores accessible markets essential components compete effectively current health care environment as result believe store development program integral part ability maintain leadership position given changing health care landscape meet increasing needs customers retail pharmacy information systems we continued invest information systems enable us deliver exceptional customer service enhance safety quality expand patient care services lowering operating costs leveraging retail pharmacy fulfillment system rxconnect proprietary wecare workflow supports pharmacy teams prioritizing work meet customer expectations facilitating prescriber outreach seamlessly integrating clinical programs this solution delivers improved efficiency enhances customer experience well providing framework accommodate evolution pharmacy practice expansion clinical programs our health engagement engine tm technology proprietary clinical algorithms enable us help identify opportunities pharmacists deliver face face counseling regarding patient health safety matters including adherence issues gaps care management certain chronic health conditions our digital strategy empowers consumer navigate pharmacy experience manage condition line mobile tools offer utility convenience this includes ability schedule appointment minuteclinic get next line alerts health reminders appointment updates via phone our integrated digital offerings help patients seamlessly manage retail mail specialty prescriptions dispensed cvspharmacy location enhance front store personalization drive value customers we experienced strong adoption digital solutions mobile app receiving critical acclaim ease use text message program experiencing significant growth retail pharmacy customers managed care organizations government funded health care programs including state medicaid plans medicare partd drug plans commercial employers third party plans accounted pharmacy revenues the loss one payor material effect business no single retail payor accounts annual consolidated revenues however success retail drugstore business dependent upon ability establish maintain contractual relationships pbms payors acceptable terms retail pharmacy seasonality the majority revenues particularly pharmacy revenues generally seasonal nature however front store revenues tend higher december holiday season in addition pharmacy front store revenues affected timing severity cough cold flu season for additional information refer risks related seasonality business item risk factors retail pharmacy competition the retail drugstore business highly competitive we believe compete principally basis istore location convenience iicustomer service satisfaction iiiproduct selection variety ivprice in markets serve compete drugstore chains eg walgreens rite aid supermarkets discount retailers eg wal mart target independent pharmacies restrictive pharmacy networks membership clubsinternet companies retail health clinics well mail order pharmacies pbms corporate segment our corporate segment provides management administrative services support overall operations company the corporate segment consists certain aspects executive management corporate relations legal compliance human resources corporate information technology finance departments generic sourcing venture in july company cardinal health inc cardinal established red oak sourcing llc red oak generic pharmaceutical sourcing entity company cardinal the red oak arrangement initial term ten years under arrangement company cardinal contributed sourcing supply chain expertise red oak agreed source negotiate generic pharmaceutical supply contracts companies red oak however red oak hold inventory behalf either company no physical assets eg property equipment contributed red oak either company minimal funding provided capitalize red oak red oak variable interest entity the company determined primary beneficiary variable interest entity ability direct activities red oak consequently company consolidates red oak consolidated financial statements within retail pharmacy segment cardinal required pay company quarterly payments million commenced october certain milestones achieved pay additional predetermined quarterly amounts company beginning third quarter working capital practices we fund growth business combination cash flow operations commercial paper proceeds sale leaseback transactions long term borrowings for additional information working capital practices refer caption managements discussion analysis liquidity capital resources annual report stockholders year ended december section incorporated reference herein the majority non pharmacy revenues paid cash debit credit cards managed care third party insurance programs typically settle less days represented approximately consolidated pharmacy revenues including retail pharmacy pharmacy services the remainder consolidated pharmacy revenues paid cash debit credit cards our customer returns significant colleague development as december employed approximately colleagues included pharmacists nurses nurse practitioners physician assistants the total included approximately part time colleagues work less hours per week to deliver highest levels service customers devote considerable time attention people service standards we emphasize attracting training knowledgeable friendly helpful associates work organization intellectual property we registered andor applied register variety trademarks service marks used throughout business well domain names rely combination copyright patent trademark trade secret laws addition contractual restrictions establish protect proprietary rights we regard intellectual property significant value pharmacy services retail pharmacy segments we aware facts could materially impact continuing use intellectual property government regulation overview much business subject federal state laws regulations in addition many pbm clients payors retail pharmacy segment including insurers managed care organizations mcos subject extensive regulations affect design implementation prescription drug benefit plans sponsor the application complex legal regulatory requirements detailed operation business creates areas uncertainty further numerous proposed health care laws regulations federal state levels could adversely affect business enacted we unable predict federal state legislation regulatory initiatives may enacted future relating business health care industry general effect legislation regulations might business any failure alleged failure comply applicable laws regulations summarized adverse applications changes laws regulations affecting business could material adverse effect operating results andor financial condition see item legal proceedings information although believe material compliance existing laws regulations applicable various business lines cannot give assurances business financial condition results operations materially adversely affected required materially change business practices based ifuture enactment new health care laws regulations iithe interpretation application existing laws regulations including laws regulations described government regulation section may relate business pharmacy services retail pharmacy retail clinic industry health care industry generally iiipending future federal state governmental investigations business pharmacy services retail pharmacy retail clinic industry health care industry generally ivinstitution government enforcement actions us vadverse developments pending qui tam lawsuit us whether sealed unsealed future qui tam lawsuit may filed us viadverse developments pending future legal proceedings us affecting pharmacy services retail pharmacy retail clinic industry health care industry generally laws regulations related each operating segment our business laws related reimbursement government programs we subject various state federal laws concerning submission claims reimbursement medicare medicaid government sponsored health care programs potential sanctions violating laws include recoupment reduction government reimbursement amounts civil penalties multiples damages exclusion participation government health care programs such laws include federal false claims act fca various state false claims acts federal stark law related state laws in particular fca prohibits intentionally submitting conspiring submit causing submitted false claims records statements federal government intentionally failing return overpayments connection reimbursement federal government programsas part aca federal anti kickback statute amended provide claim government reimbursement violates fca results violation anti kickback statute most states enacted false claims laws analogous fca federal state false claims laws permit private individuals file qui tam whistleblower lawsuits behalf federal state government further federal stark law generally prohibits physicians referring medicare medicaid beneficiaries certain services including outpatient prescription drugs entity physician immediate family member physician financial relationship the stark law prohibits entity receiving prohibited referral presenting claim reimbursement medicare medicaid services furnished pursuant prohibited referral various states enacted similar laws anti remuneration laws federal law prohibits among things entity knowingly willfully offering paying soliciting receiving subject certain exceptions safe harbors remuneration induce referral individuals purchase lease order items services payment may made medicare medicaid certain federal health care programs number states similar laws limited services paid government funds sanctions violating federal state anti remuneration laws may include imprisonment criminal civil fines exclusion participation medicare medicaid government sponsored health care programs antitrust unfair competition the federal trade commission ftc authority section federal trade commission act ftca investigate prosecute practices unfair trade practices unfair methods competition numerous lawsuits filed throughout united states pharmaceutical manufacturers retail pharmacies andor pbms various state federal antitrust unfair competition laws challenging among things ibrand drug pricing practices pharmaceutical manufacturers iithe maintenance retail pharmacy networks pbms iiivarious business practices pbms retail pharmacies to extent appear actual potential market power relevant market cvspharmacy plays unique expanded role pbm product offering business arrangements uses confidential information may subject heightened scrutiny anti competitive perspective possible challenge state federal regulators private parties privacy confidentiality requirements many activities involve receipt use disclosure us personally identifiable information pii permitted accordance applicable federal state privacy data security laws require organizations provide appropriate privacy security safeguards information in addition pii use disclose de identified data analytical purposes permitted additionally industry standards handling credit card data known payment card industry data security standard set requirements designed help ensure entities process store transmit credit card information maintain secure environment certain states recently incorporated requirements state laws the federal health insurance portability accountability act regulations issued thereunder collectively hipaa impose extensive requirements way health plans health care providers health care clearinghouses known covered entities business associates use disclose safeguard protected health information phi criminal penalties civil sanctions may imposed failing comply hipaa standards the health information technology economic clinical health act hitech act enacted part american recovery reinvestment act amended hipaa impose additional restrictions third party funded communications using phi receipt remuneration exchange phi it also extended hipaa privacy security requirements penalties directly business associates in addition hipaa state health privacy laws apply extent protective individual privacy hipaa finally health insurance marketplaces formerly known exchanges required adhere privacy security standards respect pii impose privacy security standards least protective pii health insurance marketplace implemented non health insurance marketplace entities include insurers offering plans health insurance marketplaces designated downstream entities including pbms business associates these standards may differ stringent hipaa consumer protection laws the federal government many consumer protection laws ftca federal postal service act ftcs telemarketing sales rule most states also similar consumer protection laws these laws basis investigations lawsuits multi state settlements relating among matters marketing loyalty programs health care services pricing accuracy expired front store products financial incentives provided drug manufacturers pharmacies connection therapeutic interchange programs disclosures related personal data used protected government agreements mandates the company andor various affiliates subject certain consent decrees settlement agreements corporate integrity agreements various federal state local authorities relating matters privacy practices pseudoephedrine products medicare partd prescription drug plans expired products environmental safety matters marketing advertising practices pbm pharmacy operations various business practices these agreements contain certain ongoing reporting monitoring compliance requirements company failure meet companys obligations agreements could result civil criminal remedies financial penalties administrative remedies andor exclusion participation federal health care programs environmental safety regulation our business subject various federal state local laws regulations requirements pertaining protection environment public health employee safety including example regulations governing management hazardous substances cleaning contaminated sites maintenance safe working conditions stores distribution centers facilities governmental agencies federal state local levels recent years increasingly focused retail healthcare sectors compliance laws regulations times pursued enforcement activities any failure comply regulations could result fines sanctions government authorities health reform legislation passed aca affects virtually every aspect health care country in addition establishing framework every individual health coverage aca enacted number significant health care reforms many reforms affect coverage plan designs provided health plan clients as result reforms impact number services business practices given many regulations implementing aca still finalized sub regulatory guidance still issued full impact aca company uncertain pharmacy professional licensure regulation we subject variety intersecting state federal statutes regulations govern wholesale distribution drugs operation retail specialty infusion mail order pharmacies licensure facilities professionals including pharmacists technicians nurses registration facilities united states drug enforcement administration dea analogous state agencies regulate controlled substances packaging storing shipping pharmaceuticals repackaging drug products labeling medication guides consumer disclosures interactions prescribers healthcare professionals compounding prescription medications dispensing controlled non controlled substances counseling patients transfers prescriptions advertisement prescription products pharmacy services security inventory control recordkeeping reporting boards pharmacy united states food drug administration fda consumer product safety commission dea related state agencies elements pharmacy practicepharmacies highly regulated contact wide variety local state federal agencies various powers investigate audit solicit information including boards pharmacy nursing dea fda united states department justice united states department health human services hhs othersmany agencies broad enforcement powers conduct audits regular basis impose substantial fines penalties may revoke license registration program enrollment facility professional telemarketing other outbound contacts certain federal state laws telephone consumer protection act give ftc federal communications commission fcc state attorneys general ability regulate andbring enforcement actions relating telemarketing practices certain automated outbound contacts phone calls texts emailsunder certain circumstances laws may provide consumers private right action violations laws could result substantial statutory penalties sanctions laws regulations related our pharmacy services segment in addition laws regulations discussed may affect business whole subject federal state local statutes regulations governing operation pharmacy services segment specifically among following pbm laws regulation legislation seeking regulate pbm activities comprehensive manner introduced enacted number states this legislation could adversely impact ability conduct business commercially reasonable terms states legislation effect in addition certain quasi regulatory organizations including national association boards pharmacy national association insurance commissioners naic issued model regulations may propose future regulations concerning pbms andor pbm activities similarly credentialing organizations ncqa urac may establish voluntary standards regarding pbm specialty pharmacy activities while actions quasi regulatory standard setting organizations force law may influence states adopt requirements recommendations influence client requirements pbm specialty pharmacy services moreover standards established organizations could also impact health plan clients andor services provide medicare partd the medicare part program makes prescription drug coverage available eligible medicare beneficiaries private insurers regulates aspects provision medicare drug coverage including enrollment formularies pharmacy networks marketing claims processing the medicare partd program undergone significant legislative regulatory changes since inception continues attract high degree legislative regulatory scrutiny the applicable government rulesand regulations continue evolve cms imposed restrictions issued new requirements protect medicare part beneficiaries used authority sanction impose civil monetary penalties plans non compliance network access legislation medicare part majority states form legislation affecting ability limit access pharmacy provider network remove network providers certain willing provider legislation may require us clients admit non participating pharmacy pharmacy willing able meet plans price applicable terms conditions network participation these laws could negatively impact services economic benefits achievable limited pharmacy provider network also majority states form legislation affecting ability health plans ability conduct audits network pharmacies regarding claims submitted us payment these laws could negatively impact ability recover overpayments health care payments stemming pharmacy audits lastly several states passed legislation regulating ability manage establish maximum allowable costs mac mac methodology common cost management practice used pay pharmacies dispensing generic prescription drugs including private public payors mac prices specify allowable reimbursement pbm particular strength dosage generic drug available multiple manufacturers sold different prices state legislation regulate disclosure mac prices mac price methodologies kinds drugs pbm pay mac price rights pharmacies appeal mac price established pbm these laws could negatively impact ability establish mac prices generic drugs contract audits we subject audits many contracts including pbm client contracts pbm rebate contracts contracts relating medicare partd agreement pharmacies enter payors because contracts state federal governments entities contracted state federal agencies audits agreements often regulated federal state agencies responsible administering federal state benefits programs including operate medicaid fee service plans managed medicaid plans medicare partd plans medicare advantage organizations federal employee health benefits program we contractual arrangement bluecross blueshield association provide pharmacy services federal employees postal workers annuitants dependents government wide service benefit plan authorized federal employees health benefits act fehba part federal employees health benefits programthis arrangement subjects us fehba federal regulations federal employees health benefits acquisition regulation otherwise applicable us state insurance laws pdps pbm service contracts including assume certain risk performance guarantees similar arrangements generally subject insurance regulation states however pdp silverscript subject state insurance laws limited licensure solvency in addition pbm offerings prescription drug coverage capitated basis otherwise accepting material financial risk providing pharmacy benefits may subject laws regulations various states such laws may require party risk become licensed insurer establish reserves otherwise demonstrate financial viability laws may apply cases include insurance laws laws governing mcos limited prepaid health service plans some states laws prohibit submitting false claim making false record statement order secure reimbursement insurance company these state laws vary violation may lead imposition civil criminal penalties additionally several states passed legislation governing prompt payment claims requires among things health plans payors pay claims within certain prescribed time periods pay specified interest penalties these laws vary state state regard scope requirements application erisa regulation the employee retirement income security act amended erisa provides comprehensive federal regulation certain employee pension benefit plans including private employer union sponsored health plans certain plans contract us provide pbm services in general assist plan sponsors administration prescription drug portion health benefit plans accordance plan designs adopted plan sponsors we believe conduct business subjects us fiduciary obligations erisa except specifically contracted plan sponsor accept limited fiduciary responsibility adjudication initial prescription drug benefit claims andor appeals denied claims plan respect contraceptive coverage mandate one health reforms included aca in addition fiduciary provisions erisa imposes civil criminal liability service providers health plans certain persons certain forms illegal remuneration made received these provisions erisa broadly written application specific business practices often uncertain formulary plan design regulation number government entities regulate administration prescription drug benefits hhs regulates medicare part formularies developed administered including requiring inclusion drugs certain classes categories subject limited exceptions under aca cms imposes drug coverage requirements health plans required cover essential health benefits including plans offered federal state exchanges additionally naic health care accreditation agencies like ncqa urac developed model acts standards formulary development often incorporated government requirements many states regulate scope prescription drug coverage well delivery channels receive prescriptions insurers mcos medicaid managed care plans the increasing government regulation formularies could significantly affect ability develop administer formularies networks plan design features behalf insurer mco clients similarly states prohibit health plan sponsors implementing certain restrictive design features this regulation could limit preclude limited networks ii requirement use particular providers iii copayment differentials among providers iv formulary tiering practices managed care reform in addition health reforms enacted aca proposed legislation considered state level legislation enacted several states aimed primarily providing additional rights access drugs individuals enrolled managed care plans this legislation may impact design implementation prescription drug benefit plans sponsored pbm health plan clients andor services provide both scope managed care reform proposals considered state legislatures reforms enacted states date vary greatly scope future legislation may enacted uncertain disease management services regulation we provide disease management programs pbm plan members rare medical conditions arrange receive disease management programs common medical conditions state laws regulate practice medicine practice pharmacy practice nursing clinicians engaged professional practice connection provision disease management services must satisfy applicable state licensing requirements must act within scope practice third party administration other state licensure laws many states licensure registration laws governing certain types administrative organizations preferred provider organizations third party administrators companies provide utilization review services several states also licensure registration laws governing organizations provide administer consumer card programs also known cash card discount card programs laws regulations related our retail pharmacy segment in addition laws regulations discussed may affect business whole subject federal state local statutes regulations governing operation retail pharmacy segment specifically among following specific fda regulation the fda generally authority among things regulate manufacture distribution sale labeling many products sold retail pharmacies including prescription drugs counter medications medical devices including mobile medical devices cosmetics dietary supplements certain food items retail clinics states regulate retail clinics operated nurse practitioners physician assistants physician oversight lab licensing prohibition corporate practice medicine number states implemented proposed laws regulations impact certain components retail clinic operations physician oversight signage third party contracting requirements bathroom facilities scope services these laws regulations may affect operation expansion owned managedretail clinics available information cvs health corporation delaware corporation our corporate office located one cvs drive woonsocket rhode island telephone our common stock listed new york stock exchange trading symbol cvs general information cvs health available companys web site httpwwwcvshealthcom our financial press releases filings united states securities exchange commission sec available free charge within investors section web site httpwwwcvshealthcominvestors in addition sec maintains internet site contains reports proxy information statements information regarding issuers company file electronically sec the address web site httpwwwsecgov itema risk factors our business subject various industry economic regulatory risks uncertainties our business financial condition results operations cash flows prospects could materially adversely affected one following risk factors additional risks uncertainties presently known us currently deem immaterial risks declining gross margins pbm retail pharmacy the pbm industry experiencing margin pressure result competitive pressures increased client demands lower prices enhanced service offerings andor higher service levels in regard maintain contractual relationships generic pharmaceutical manufacturers brand name pharmaceutical manufacturers provide purchase discounts andor rebates drugs dispensed pharmacies retail network mail order pharmacies portion may passed clients manufacturer rebates often depend pbms ability meet contractual market share requirements including cases placement manufacturers products pbms formularies if lose relationship one pharmaceutical manufacturers discounts rebates provided pharmaceutical manufacturers decline business financial results could adversely affected further competitive pressures pbm industry resulted clients sharing larger portion rebates andor discounts received pharmaceutical manufacturers market dynamics regulatory changes impacted ability offer plan sponsors pricing includes use retail differential spread could negatively impact future profitability further changes existing federal state laws regulations adoption new laws regulations relating patent term extensions purchase discount rebate arrangements pharmaceutical manufacturers formulary management pbm services could also reduce discounts rebates receive in addition changes federal state laws regulations adoption new laws regulations relating claims processing billing including ability collect transmission fees could adversely impact profitability our retail pharmacy segment also impacted margin pressures described including client demands lower prices generic pricing network reimbursement pressure in addition competition increases markets operate significant increase general pricing pressures could occur could require us reevaluate pricing structures remain competitivein addition many pharmacy benefit plans implemented plan designs mandate provide incentives fill maintenance medications mail order pharmacies to extent trend continues negative impact retail pharmacy could outweigh increase mail order business andor increase participation maintenance choice program efforts reduce reimbursement levels alter health care financing practices the continued efforts health maintenance organizations managed care organizations pbm companies government entities third party payors reduce prescription drug costs pharmacy reimbursement rates may impact profitability in particular increased utilization generic pharmaceuticals normally yield higher gross profit rate equivalent brand named drugs resulted pressure decrease reimbursement payments retail mail order pharmacies generic drugs causing reduction generic profit rate historically effect trend generic profitability mitigated efforts negotiate reduced acquisition costs generic pharmaceuticals manufacturers however recent years significant consolidation within generic manufacturing industry possible external factors may enhance ability manufacturers sustain increase pricing generic pharmaceuticals diminish ability negotiate reduced acquisition costs any inability offset increased costs modify activities lessen impact could significant adverse effect results operations in addition past several years united states health care industry subject increase governmental regulation audits federal state levels efforts control health care costs including prescription drug costs continuing federal state government levels changing political economic regulatory influences may significantly affect health care financing reimbursement practices change composition pharmacy prescription volume toward programs offering lower reimbursement rates could negatively impact profitability aca made several significant changes medicaid rebates reimbursement one changes revise definition average manufacturer price pricing element common payment formulas reimbursement formula multi source ie generic drugs in addition aca made changes affect coverage plan designs provided many health plan clients including requirement health insurers meet minimum medical loss ratio avoid pay rebates enrollees these aca changes may affect business directly could indirectly impact services andor business practices highly competitive business environment each retail pharmacy business pharmacy services business currently operates highly competitive evolving health care environment our competitive success impacted ability retail pharmacy business establish maintain contractual relationships pbms payors acceptable terms ability pharmacy services business establish maintain contractual relationships network pharmacies environment pbm clients considering adopting narrow restricted retail pharmacy networks as pharmacy retailer compete drugstore chains supermarkets discount retailers independent pharmacies membership clubsinternet companies convenience stores mass merchants many expanding markets serve we also face competition retail health clinics well mail order pharmacies pbmsin addition competitors may offer services pricing terms may willing able offer competition may also come sources future competitors pbm industry eg express scripts optumrx catamaran prime therapeutics medimpact humana include large national pbm companies pbms owned large national health plans smaller standalone pbmssome competitors may offer services pricing terms may willing able offer in addition competition may also come sources future unless demonstrate enhanced value clients innovative product service offerings particularly rapidly changing industry may unable remain competitive in addition changes overall composition pharmacy networks reduced pharmacy access networks could adversely affect claims volume andor competitiveness generally risks related compliance broad complex regulatory framework our business subject numerous federal state local laws regulations see business government regulation in addition past several years united states health care industry subject increase governmental regulation enforcement activity federal state levels changes regulations may require extensive system operating changes may difficult implement untimely compliance noncompliance applicable laws regulations could adversely affect continued operation business including limited imposition civil criminal penalties suspension disgorgement payments government programs loss required government certifications approvals loss authorizations participate exclusion government reimbursement programs medicare medicaid programs loss registrations licensure the regulations subject include limited laws regulations described government regulation section accounting standards securities laws regulations tax laws regulations laws regulations relating protection environment health safety matters including governing exposure management disposal hazardous materials wastes laws regulations ftc fcc consumer product safety commission well state regulatory authorities governing sale advertisement promotion products sell boards pharmacy the fda dea various states regulate distribution pharmaceuticals controlled substanceswe required hold valid dea state level registrations licenses meet various security operating standards comply controlled substances act accompanying regulations governing sale marketing packaging holding distribution controlled substancesthe dea fda state regulatory authorities broad enforcement powers including ability suspend registrations licenses seize recall products impose significant criminal civil administrative sanctions violations laws regulations in addition business interests outside united states subject foreign corrupt practices act applicable domestic international laws regulations we also subject terms various government agreements mandates including described government regulation section in regard business financial position results operations could adversely affected existing new government legislative regulatory action enforcement activity including without limitation one following federal state laws regulations concerning submission claims reimbursement medicare medicaid government programs federal state laws regulations governing purchase distribution tracking management compounding dispensing reimbursement prescription drugs related services whether retail mail applicable registration licensing requirements effect expiration patents covering brand name drugs introduction generic products frequency rate approvals fda new brand name generic drugs counter status brand name drugs rulesand regulations issued pursuant hipaa hitech act federal state laws affecting collection use disclosure transmission health personal information federal laws information privacy precipitated concerns information collection internet state security breach laws state laws limiting use disclosure prescriber information consumer protection laws affecting health care services loyalty programs products sell informational calls make andor marketing goods services federal state local environmental health safety laws regulations applicable business including management hazardous substances storage transportation hazardous materials various recordkeeping disclosure procedure requirements promulgated occupational safety health administration may apply operations health care reform managed care reform plan design legislation fda regulation affecting retail pbm industry government regulation development administration review updating formularies drug lists including requirements andor limitations around formulary tiering patient cost sharing federal state laws regulations establishing changing prompt payment requirements payments retail pharmacies impact network access legislation regulations including willing provider laws ability manage pharmacy networks administration medicare partd including legislative changes andor cms rulemaking interpretation insurance licensing insurance regulatory requirements applicable offering medicare partd programs services health care services government regulation allowing importation prescription drugs canada elsewhere united states direct regulation pharmacies pbms regulatory quasi regulatory bodies the health economy general markets serve our business affected economy general including changes consumer purchasing power preferences andor spending patterns although economic recovery might underway possible worsening economic environment cause decline drug utilization dampen demand pharmacy benefit management services well consumer demand products sold retail stores further interest rate fluctuations changes capital market conditions regulatory changes may affect ability obtain necessary financing acceptable terms ability secure suitable store locations acceptable terms ability execute sale leaseback transactions acceptable terms these circumstances could result adverse effect business financial results the possibility pbm client loss andor failure win new pbm business our pbm business generates net revenues primarily contracting clients provide prescription drugs related health care services plan members pbm client contracts often terms approximately three years duration approximately one third pbms client base typically subject renewal year in cases however pbm clients may negotiate shorter longer contract term may require early periodic renegotiation pricing prior expiration contract in addition reputational impact service related incident could negatively affect ability grow retain client base further pbm industry impacted consolidation activity may continue future in event one pbm clients acquired entity also client may unable retain portion acquired business these circumstances either individually aggregate could result adverse effect business financial results therefore continually face challenges competing new pbm business retaining renewing existing pbm business there assurance able win new business secure renewal business terms favorable us present terms risks related frequency rate introduction generic drugs brand name prescription products the profitability business dependent upon utilization prescription drug products utilization trends affected among factors introduction new successful prescription pharmaceuticals well lower priced generic alternatives existing brand name products accordingly business could impacted slowdown introduction new successful prescription pharmaceuticals andor generic alternatives sale normally yield higher gross profit margins brand name equivalents the failure disruption information technology systems information security systems infrastructure support business protect privacy security sensitive customer business information many aspects operations dependent information systems information collected processed stored handled systems we rely heavily computer systems manage ordering pricing point sale pharmacy fulfillment inventory replenishment claims processing extracare customer loyalty program finance human resource processes throughout operations receive retain transmit certain confidential information including pii customers clients provide purchase products services enroll programs services register websites interact personnel otherwise communicate us in addition operations depend part secure transmission confidential information public networks our information systems subject damage interruption power outages computer telecommunications failures computer viruses security breaches including credit card information breaches vandalism catastrophic events human error although deploy layered approach address information security threats vulnerabilities including ones cybersecurity standpoint designed protect confidential information data security breaches compromise information security controls businesses interact results confidential information accessed obtained damaged used unauthorized improper persons could harm reputation expose us regulatory actions claims customers clients financial institutions payment card associations persons could adversely affect business financial position results operations moreover data security breach could require expend significant resources related information systems infrastructure could distract management key personnel performing primary operational duties if information systems damaged fail work properly otherwise become unavailable unable successfully complete planned consolidation pbm claims adjudication platforms may incur substantial costs repair replace may experience reputational damage loss critical information customer disruption interruptions delays ability perform essential functions implement new innovative services in addition compliance changes privacy information security laws standards may result considerable expense due increased investment technology development new operational processes risks relating market availability suppliers safety profiles ofprescription drugs purchase sell we dispense significant volumes brand name generic drugs retail mail order pharmacies pbms network retail pharmacies when increased safety risk profiles manufacturing supply issues specific drugs classes drugsoccur drugs become subject greater restrictions controlled substances physicians may cease writingprescriptions drugs theutilization drugs may otherwise reducedfor example october final dea rule moving hydrocodone combination products schedule iii schedule ii became effective additionallyadverse publicity regarding drugs higher safety risk profiles may result reduced consumer demand drugs on occasion products withdrawn manufacturers transition counter products result lower prescription utilizationin addition future fda rulings could restrict supply increase cost products sold customers our volumes net revenues profitability cash flows may decline result regulatory rulings market changes regulatory business changes relating participation medicare partd since inception medicare partd resulted increased utilization decreased pharmacy gross margin rates due regulatory competitive pressures further result aca changes retiree drug subsidy rules pbm clients could decide discontinue providing prescription drug benefits medicare eligible members to extent occurs adverse effects increasing customer migration medicare partd may outweigh benefits realize growth medicare partd business in addition cost complexity medicare partd exceed managements expectations prevent effective program implementation administration changes regulations regarding drug costs reported medicare partd implemented manner impacts profitability medicare partd business changes regulations impact ability retain fees third parties including network pharmacies government alters medicare program requirements reduces funding higher anticipated cost taxpayers medicare partd reasons fail design maintain programs attractive medicare participants cms imposes restrictions medicare partd business result audits regulatory actions fail successfully implement corrective action remedial measures sufficient prevent remove applicable restrictions may imposed cms successful retaining enrollees winning contract renewals new contracts medicare partds competitive bidding process medicare partd services ability expand medicare partd services could negatively impacted reform united states health care system congressional efforts reform united states health care system finally came fruition passage aca resulting significant structural changes health insurance system see business government regulation although many structural changes enacted aca implemented applicable regulations sub regulatory guidance yet issued andor finalized therefore remains considerable uncertainty full impact aca business while reforms may affect business directly affect coverage plan designs provided many health plan clients including plan designs include limited networks requirement use mail service pharmacies certain medications formulary tiering as result could indirectly impact many services business practices we cannot predict effect aca changes may retail pharmacy pharmacy services businesses possible legislative market driven changes health care system cannot anticipate could also occur possible changes industry pricing benchmarks it possible pharmaceutical industry regulators may evaluate andor develop alternative pricing reference replace average wholesale price awp pricing reference used many pbm client contracts pharmaceutical purchase agreements retail network contracts specialty payor agreements contracts third party payors connection reimbursement drug payments future changes use awp published pricing benchmarks used establish pharmaceutical pricing including changes basis calculating reimbursement federal state health programs andor payors could impact reimbursement receive medicare medicaid programs reimbursement receive pbm clients payors andor ability negotiate rebates andor discounts pharmaceutical manufacturers wholesalers pbms retail pharmacies the effect possible changes business cannot predicted time product liability product recall personal injury issues could damage reputation failure maintain adequate liability insurance coverage the products sell could become subject contamination product tampering mislabeling recall damagein addition errors dispensing packaging pharmaceuticals could lead serious injury deathproduct liability personal injury claims may asserted us respect products pharmaceuticals sell services provide our business involves provision professional services including pharmacists nurses nurse practitioners exposes us professional liability claimsshould product liability issue arise coverage limits insurance programs indemnification amounts available us may adequate protect us claimswe also may able maintain insurance acceptable terms futuredamage reputation event product liability personal injury issue judgment us product recall could significant adverse effect business financial condition results operations relationship retail customers demand products services including propriety brands the success business depends part customer loyalty superior customer service ability persuade customers purchase products additional categories proprietary brands failure timely identify effectively respond changing consumer preferences spending patterns inability expand products purchased clients customers failure inability obtain offer particular categories products could negatively affect relationship clients customers demand products services we offer retail customers proprietary brand products available exclusively retail stores online retail sites the sale proprietary products subjects us unique risks including potential product liability risks mandatory voluntary product recalls ability successfully protect intellectual property rights rights applicable third parties risks generally encountered entities source market sell private label products any failure adequately address risks could adverse effect business results operations financial condition additionally increase sales proprietary brands may negatively affect sales products owned suppliers consequently could adversely impact certain supplier relationships our ability locate qualified economically stable suppliers satisfy requirements acquire sufficient products timely effective manner critical ensuring among things customer confidence diminished any failure develop sourcing relationships broad deep supplier base could adversely affect financial performance erode customer loyalty finally customer expectations new technology advances competitors required business evolve able interface retail customers face face stores also online via mobile social media our customers using computers tablets mobile phones electronic devices shop stores online well provide public reactions concerning facet operation if fail keep pace dynamic customer expectations new technology developments ability compete maintain customer loyalty could adversely affected risks related seasonality business although majority revenues particularly pharmacy revenues generally seasonal nature front store revenues tend higher december holiday season uncharacteristic extreme weather conditions adversely impact consumer shopping patterns well this could lead lost sales well increased snow removal costs thereby negatively affecting short term results operations in addition pharmacy front store revenues affected timing severity cough cold flu season susceptible large fluctuations year year risks related litigation legal proceedings pharmacy services retail pharmacy highly regulated litigious industries we currently subject various litigation matters investigations audits government inquiries regulatory legal proceedings litigation particularly securities collective class action litigation often expensive disruptive we cannot predict outcome matters costs incurred may substantial regardless outcome our business financial condition results operations may adversely affected may required materially change business practices result proceedings we refer item legal proceedings additional information the foregoing comprehensive listing possible risks assurance correctly identified appropriately assessed factors affecting business as refer managements discussion analysis financial condition results operations includes cautionary statement concerning forward looking statements end section annual report stockholders year ended december section incorporated reference herein itemb unresolved staff comments there unresolved sec staff comments item properties we lease stores long term leases vary rental amounts expiration dates renewal options rental provisions for additional information amount rental obligations leases refer note leases annual report stockholders year ended december section incorporated reference herein as december owned approximately retail stores net selling space retail drugstores approximately million square feet december more one third store base opened significantly remodeled within last five years we nine distribution centers located alabama california hawaii new york rhode island south carolina tennessee texas lease additional distribution facilities located arizona floridaindiana michigan new jersey pennsylvania texas virginia brazil the distribution centers total approximately million square feet december as december owned one mail service dispensing pharmacy located texas leased three additional mail order dispensing pharmacies located hawaiiillinois pennsylvania we leased call centers located missouri pennsylvania tennessee texas as december leased onsite pharmacy stores specialty pharmacy stores operated specialty mail order pharmacies we leased branches six centers excellence infusion enteral services we corporate offices located woonsocket rhode island totals approximately square feet in addition lease large corporate offices scottsdale arizona northbrookillinois monroeville pennsylvania irving texas sao paulo brazil in connection certain business dispositions completed continue guarantee lease obligations approximately former stores we indemnified guarantee obligations respective purchasers these guarantees generally remain effect initial lease term extension thereof pursuant renewal option provided lease prior time disposition for additional information refer note commitmentsand contingencies annual report stockholders year ended december section incorporated reference herein management believes owned leased facilities suitable adequate meet companys anticipated needs at end existing lease terms management believes leases renewed replaced alternate space the following breakdown state district columbia puerto rico brazil retail stores onsite pharmacy stores specialty pharmacy stores specialty mail order pharmacies mail order dispensing pharmacies branches centers excellence infusion enteral services december retailstores onsite pharmacy stores specialty pharmacy stores specialty mailorder pharmacies mail order dispensing pharmacies infusion enteral services locations total united states alabama arkansas arizona california colorado connecticut delaware district columbia florida georgia hawaii idaho iowa illinois indiana kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania puerto rico rhode island south carolina tennessee texas utah vermont virginia washington west virginia wisconsin total united states brazil total item legal proceedings legal proceedings we refer note commitments contingencies legal matters contained notes consolidated financial statements annual report stockholders year ended december section incorporated reference herein item mine safety disclosures not applicable executive officers registrant executive officers registrant the following sets forth name age biographical information executive officers february in case officers term office extends date board directors meeting following next annual meeting stockholders company previous positions responsibilities held executive officers past five years indicated lisa bisaccia age senior vice president chief human resources officer cvs health corporation since january vice president human resources cvs pharmacyinc september december eva boratto age senior vice president controller chief accounting officer cvs health corporation since july senior vice president pbm finance july june vice president us market finance leader merck co inc june june troyen brennan md age executive vice president chief medical officer cvs health corporation since november executive vice president chief medical officer aetnainc february november david denton age executive vice president chief financial officer cvs health corporation since january senior vice president controllerchief accounting officer cvs health corporation march december senior vice president financial administration cvs health corporation cvs pharmacyinc april march mr denton also member board directors coach inc leading retailer premium bags luxury accessories helena foulkes age executive vice president cvs health corporation president cvspharmacy since january executive vice president chief health care strategy marketing officer cvs health corporation march december executive vice president chief marketing officer cvs health corporation january february senior vice president health services cvs health corporation may january cvs pharmacyinc october january ms foulkes also member board directors the home depot inc leading home improvement retailer stephen gold age senior vice president chief information officer cvs health corporation since july senior vice president chief information officer avayainc may june executive vice president chief information officer chief technology officer gsi commerceinc february april david joyner age executive vice president cvs health corporation since march executive vice president sales account services cvscaremark since march per gh lofberg age executive vice president cvs health corporation executive vice president cvs health corporation president cvscaremark january august president chief executive officer generation healthinc pharmacogenomics company november december larry merlo age president chief executive officer cvs health corporation since march president chief operating officer cvs health corporation may march president cvspharmacy january august executive vice president cvs health corporation january may also director cvs health corporation since may thomas moriarty age executive vice president general counsel cvs health corporation since october chief health strategy officer since march general counsel celgene corporation global biopharmaceutical company may september general counsel corporate secretary medco health solutionsinc medco pharmacy benefit management company march april also president global pharmaceutical strategies medco march april senior vice president pharmaceutical strategies solutions medco september march jonathan roberts age executive vice president cvs health corporation president cvscaremark since september executive vice president cvs health corporation chief operating officer cvscaremark october august executive vice president rx purchasing pricing network relations cvs health corporation january october senior vice president chief information officer cvs health corporation may january cvs pharmacyinc january january andrew sussman md age senior vice president associate chief medical officer cvs health corporation since march president cvsminuteclinic since september executive vice president chief operating officer university massachusetts memorial medical center major teaching affiliate umass medical school may august partii item market registrants common equity related stockholder matters issuer purchases equity securities our common stock listed new york stock exchange symbol cvs the table sets forth high low sale prices common stock new york stock exchange composite tape quarterly cash dividends declared per share common stock periods indicated firstquarter secondquarter thirdquarter fourthquarter year high low cash dividends per common share high low cash dividends per common share cvs health paid cash dividends every quarter since becoming public company future dividend payments depend companys earnings capital requirements financial condition factors considered relevant companys board directors as february registered shareholders according records maintained transfer agent on december companys board directors authorized new share repurchase program billion outstanding common stock repurchase program on december companys board directors authorized share repurchase program billion outstanding common stock repurchase program on september companys board directors authorized share repurchase program billion outstanding common stock repurchase program together repurchase programs repurchase programs the repurchase programs effective immediately permit company effect repurchases time time combination open market repurchases privately negotiated transactions accelerated share repurchase transactions andor derivative transactions the repurchase programs may modified terminated board directors time the repurchase program complete indicated during year ended december company repurchased aggregate million shares common stock approximately billion repurchase programs as december remained aggregate approximately billion available future repurchases repurchase programs as decemer repurchase program complete pursuant authorization repurchase programs effective january entered billion fixed dollar accelerated share repurchase asr agreement jp morgan chase bank jp morgan upon payment billion purchase price january received number shares common stock equal billion notional amount asr agreement approximately million shares price per share at conclusion asr program company may receive additional shares equal remaining billion notional amount the ultimate number shares company may receive fluctuate based changes daily volume weighted average price companys stock period beginning january ending april if mean daily volume weighted average price companys common stock less discount forward price asr program falls per share company receive higher number shares jp morgan if forward price rises per share company either receive fewer shares jp morgan potentially obligation jp morgan companys option could settled additional cash issuing shares under terms agreement maximum number shares could received delivered million the initial million shares common stock delivered company jp morgan placed treasury stock january fiscalperiod totalnumber ofshares purchased average pricepaidper share totalnumberofshares purchasedaspartof publiclyannounced plansorprograms approximatedollar valueofsharesthat mayyetbe purchasedunderthe plansorprograms october october november november december december item selected financial data the selected consolidated financial data cvs health corporation periods indicated five year period ended december derived consolidated financial statements cvs health corporation the selected consolidated financial data read conjunction consolidated financial statements audit reports ernst young llp incorporated elsewhere herein inmillionsexceptpershareamounts statement operations data net revenues gross profit operating expenses operating profit interest expense net loss early extinguishment debt income tax provision income continuing operations income loss discontinued operations net tax net income net loss attributable noncontrolling interest net income attributable cvs health per common share data basic earnings per common share income continuing operations attributable cvs health loss discontinued operations attributable cvs health net income attributable cvs health diluted earnings per common share income continuing operations attributable cvs health loss discontinued operations attributable cvs health net income attributable cvs health cash dividends per common share balance sheet data total assets long term debt total shareholders equity number stores end year income tax provision year ended december includes effect recognition million previously unrecognized tax benefits including interest relating expiration various statutes limitation settlements tax authorities item managements discussion analysis financial condition results operations we refer managements discussion analysis financial condition results operations includes cautionary statement concerning forward looking statements end section annual report stockholders year ended december section incorporated reference herein itema quantitative qualitative disclosures market risk as december company derivative financial instruments derivative commodity instruments place believes exposure market risk associated financial instruments principally interest rate risk inherent debt portfolio material item financial statements supplementary data we refer consolidated statements income consolidated statements comprehensive income consolidated balance sheets consolidated statements shareholders equity consolidated statements cash flows notes consolidated financial statements report independent registered public accounting firm annual report stockholders fiscal year ended december sections incorporated reference herein item changes disagreements accountants accounting financial disclosure none itema controls procedures evaluation disclosure controls procedures the companys chief executive officer chief financial officer evaluating effectiveness design operation companys disclosure controls procedures defined rulesa fand securities exchange act december concluded date companys disclosure controls procedures adequate effective reasonable assurance level designed ensure material information relating company subsidiaries would made known officers timely basis internal control financial reporting we refer managements report internal control over financial reporting report independent registered public accounting firm annual report stockholders fiscal year ended december incorporated reference herein managements report companys internal control financial reporting independent registered public accounting firms report respect effectiveness internal control financial reporting changes internal control financial reporting there changes internal controls financial reporting identified connection evaluation required paragraph dof rulea ruled occurred fourth quarter ended december materially affected reasonably likely materially affect internal control financial reporting itemb other information no events occurred fourth quarter would require disclosure item partiii item directors executive officers corporate governance we refer proxy statement annual meeting stockholders captions committees board code conduct director nominations audit committee report biographies board nominees sectionabeneficial ownership reporting compliance sections incorporated reference herein biographical information executive officers contained parti annual report form item executive compensation we refer proxy statement annual meeting stockholders captions executive compensation related matters including compensation discussion analysis management planning development committee report sections incorporated reference herein item security ownership certain beneficial owners management related stockholder matters we refer proxy statement annual meeting stockholders captions share ownership directors certain executive officers share ownership principal stockholders sections incorporated reference herein information concerning security ownership certain beneficial owners management related stockholder matters the following table summarizes information companys common stock may issued upon exercise options warrants rights equity compensation plans december numberof securitiestobe issuedupon exerciseof outstanding optionswarrants andrights weighted averageexercise priceof outstanding optionswarrants andrights numberofsecurities remainingavailablefor futureissuanceunder equitycompensation plansexcluding securitiesreflectedin firstcolumn equity compensation plans approved stockholders equity compensation plans approved stockholders total shares thousands item certain relationships related transactions director independence we refer proxy statement annual meeting stockholders caption independence determinations directors certain transactions directors officers sections incorporated reference herein item principal accountant fees services we refer proxy statement annual meeting stockholders caption item ratification appointment independent registered public accounting firm section incorporated reference herein partiv item exhibits financial statement schedules documents filed part report financial statements the following financial statements incorporated reference annual report stockholders fiscal year ended december provided item hereof consolidated statements income years ended december consolidated statements comprehensive income years ended december consolidated balance sheets december consolidated statements cash flows years ended december consolidated statements shareholders equity years ended december notes consolidated financial statements report independent registered public accounting firm financial statement schedules all financial statement schedules omitted applicable required instructions information included consolidated financial statements related notes exhibits exhibits marked asterisk hereby incorporated reference exhibits appendices previously filed registrant indicated brackets following description exhibit exhibit description agreement plan merger dated november among registrant caremark rxinc twain mergersub corp incorporated reference exhibit registrants registration statement no forms filed december amendment no dated january agreement plan merger dated november among registrant caremark rxinc twain merger sub corp incorporated reference exhibit registrants registration statement no forms filed january waiver agreement dated january registrant caremark rxinc respect agreement plan merger dated november registrant caremark rxinc incorporated reference exhibit registrants registration statement no forms filed january amendment waiver agreement dated february registrant caremark rxinc incorporated reference exhibit registrants current report form dated february commission file no amendment waiver agreement dated march registrant caremark rxinc incorporated reference exhibit registrants current report form dated march commission file no agreement plan merger dated august among registrant longs drug stores corporation blue mergersub corp incorporated reference exhibit registrants current report form dated august commission file no amended restated certificate incorporation registrant incorporated reference exhibit registrants annual report form fiscal year ended december commission file no certificate amendment amended restated certificate incorporation effective may incorporated reference exhibita registrants registration statement no forms dated may certificate amendment amended restated certificate incorporation incorporated reference exhibit registrants current report form dated march commission file no certificate merger dated may incorporated reference exhibitc registrants quarterly report form dated november commission file no certificate amendment amended restated certificate incorporation incorporated reference exhibit registrants current report form dated may commission file no certificate amendment amended restated certificate incorporation incorporated reference exhibit registrants current report on form dated may commission file no certificate amendment amended restated certificate incorporation incorporated reference exhibit registrants current report form dated september commission file no by laws registrant amended restated incorporated reference exhibit registrants current report form dated september commission file no pursuant regulation kitem biiia instrument defines rights holders long term debt registrant subsidiaries filed report the registrant hereby agrees furnish copy instrument securities exchange commission upon request specimen common stock certificate incorporated reference exhibit registration statement registrant form dated november commission file no stock purchase agreement dated october the tjx companiesinc melville corporation amended november incorporated reference exhibits melvilles current report form dated december commission file no stock purchase agreement dated march melville corporation consolidated stores corporation amended may incorporated reference exhibits melvilles current report form dated may commission file no distribution agreement dated september among melville corporation footstarinc footstar centerinc incorporated reference exhibit melvilles current report form dated october commission file no tax disaffiliation agreement dated september among melville corporation footstarinc certain subsidiaries named therein incorporated reference exhibit melvilles current report form dated october commission file no stockholder agreement dated december registrant nashua hollis cvsinc linens thingsinc incorporated reference exhibitito registrants annual report form fiscal year ended december commission file no tax disaffiliation agreement dated december registrant linens thingsinc certain respective affiliates incorporated reference exhibitito registrants annual report form fiscal year ended december commission file no four year credit agreement dated may among registrant lenders party thereto barclays capital jp morgan chase bank na co syndication agents bank america na wells fargo bank na co documentation agents bank new york mellon administrative agent incorporated reference exhibit registrants quarterly report form fiscal quarter ended june commission file no amendment no dated november credit agreement dated may among registrant lenders party thereto co syndication agents co documentation agents named therein the bank new york mellon administrative agent incorporated reference exhibit registrants annual report form fiscal year ended december commission file no five year credit agreement dated february among registrant lenders party thereto barclays capital jpmorgan chase bank na co syndication agents bank america na wells fargo bank na co documentation agents the bank new york mellon administrative agent incorporated reference exhibit registrants quarterly report form fiscal quarter ended march commission file no credit agreement dated may among registrant lenders party thereto barclays bank plc jpmorgan chase bank na co syndication agents bank america na wells fargo bank na co documentation agents the bank new york mellon administrative agent incorporated reference exhibit registrants quarterly report form fiscal quarter ended june commission file no amendment no dated may credit agreement dated may among registrant lenders party thereto barclays capital jpmorgan chase bank na co syndication agents bank america na wells fargo bank na co documentation agents the bank america na wells fargo bank na co documentation agents the bank new york mellon administrative agent previously amended amendment no dated november incorporated reference exhibit registrants quarterly report form fiscal quarter ended june commission file no second amended restated credit agreement dated july among registrant lenders party thereto barclays bank plc jpmorgan chase bank na co syndication agents bank america na wells fargo bank na co documentation agents the bank new york mellon administrative agent incorporated reference exhibit registrants quarterly report form quarter ended june commission file no supplemental retirement plan select senior management cvs health corporation amended restated december incorporated reference exhibit registrants quarterly report form quarter ended june commission file no cvs health corporation directors stock plan amended restated november incorporated reference exhibit registrants annual report form fiscal year ended december commission file no incentive compensation plan amended december incorporated reference exhibit registrants quarterly report form quarter ended june commission file no caremark rxinc incentive stock plan incorporated reference exhibit registrants registration statement no forms filed march commission file no cvs health deferred stock compensation plan incorporated reference exhibit registrants quarterly report form quarter ended june commission file no cvs health deferred compensation plan amended restated december incentive compensation plan amended january incorporated reference exhibit registrants annual report form fiscal year ended december commission file no employee stock purchase plan incorporated reference exhibitd registrants definitive proxy statement filed april commission file no the registrants management incentive plan the registrants executive incentive plan the registrants long term incentive plan incorporated reference exhibit registrants annual report form fiscal year ended december commission file no the registrants partnership equity program amended december the registrants severance plan non store employees amended april incorporated reference exhibit registrants annual report form year ended december commission file no the registrants performance based restricted stock unit plan amended december form enterprise non competition non disclosure developments agreement registrant certain registrants executive officers incorporated reference exhibit registrants annual report form year ended december commission file no universal definition document dated december incorporated reference exhibit registrants quarterly report form quarter ended june commission file no formof non qualified stock option agreement registrant selected employees registrant formof restricted stock unit agreement annual grant registrant selected employees registrant formof performance based restricted stock unit agreement registrant selected employees registrant formof partnership equity program participant purchased rsus company matching rsus company matching options agreement pre tax formof partnership equity program participant purchased rsus company matching rsus company matching options agreement post tax amended restated employment agreement dated december registrant registrants president chief executive officer incorporated reference exhibit registrants annual report form fiscal year ended december commission file no amendment dated december amended restated employment agreement dated december registrant registrants president chief executive officer incorporated reference exhibit registrants annual report form fiscal year ended december commission file no formof non qualified stock option agreement registrant registrants president chief executive officer formof restricted stock unit agreement registrant registrants president chief executive officer amendment dated january nonqualified stock option agreements registrant registrants president chief executive officer incorporated reference exhibit registrants current report form dated january commission file no change control agreement dated december registrant registrants executive vice president chief financial officer incorporated reference exhibit registrants annual report form fiscal year ended december commission file no amendment dated december change control agreement dated december registrant registrants executive vice president chief financial officer incorporated reference exhibit registrants annual report form fiscal year ended december commission file no change control agreement dated december registrant registrants executive vice president president cvscaremark incorporated reference exhibit registrants annual report form fiscal year ended december commission file no amendment dated december change control agreement dated december registrant registrants executive vice president president cvscaremark incorporated reference exhibit registrants annual report form fiscal year ended december commission file no change control agreement dated december registrant registrants executive vice president president cvspharmacy amendment dated december change control agreement registrant registrants executive vice president president cvspharmacy change control agreement dated december registrant registrants executive vice president chief medical officer incorporated reference exhibit registrants annual report form year ended december commission file no portions annual report stockholders cvs health corporation specifically designated form incorporated reference subsidiaries registrant consent ernst young llp certification chief executive officer pursuant section sarbanes oxley act certification chief financial officer pursuant section sarbanes oxley act certification chief executive officer pursuant section sarbanes oxley act certification chief financial officer pursuant section sarbanes oxley act the following materials cvs health corporation annual report form year ended december formatted extensible business reporting language xbrl ithe consolidated statements income iithe consolidated balance sheets iiithe consolidated statements cash flows ivrelated notes signatures pursuant requirements section dof securities exchange act registrant duly caused annual report form signed behalf undersigned thereunto duly authorized cvs health corporation date february by sdavid denton david denton executive vice president chief financial officer pursuant requirements securities exchange act report signed following persons behalf registrant capacities dates indicated signature titles date richard bracken director february richard bracken sc david brown ii director february david brown ii eva boratto senior vice president controller chief accounting officer principal accounting officer february eva boratto sdavid denton executive vice president chief financial officer principal financial officer february david denton nancy ann deparle director february nancy ann deparle sdavid dorman chairman board director february david dorman sanne finucane director february anne finucane slarry merlo president chief executive officer principal executive officer director february larry merlo sjean pierre millon director february jean pierre millon srichard swift director february richard swift swilliam weldon director february william weldon stony white director february tony white